A comparison of basal insulin delivery - Continuous subcutaneous insulin infusion versus glargine

被引:14
作者
King, AB [1 ]
Armstrong, D [1 ]
机构
[1] Diabet Care Res Ctr, Salinas, CA 93901 USA
关键词
D O I
10.2337/diacare.26.4.1322
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1322 / 1322
页数:1
相关论文
共 3 条
[1]   Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy [J].
Heller, SR ;
Amiel, SA ;
Mansell, P .
DIABETES CARE, 1999, 22 (10) :1607-1611
[2]   Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro [J].
Lepore, M ;
Pampanelli, S ;
Fanelli, C ;
Porcellati, F ;
Bartocci, L ;
Di Vincenzo, A ;
Cordoni, C ;
Costa, E ;
Brunetti, P ;
Bolli, GB .
DIABETES, 2000, 49 (12) :2142-2148
[3]  
LANTUS PRESCRIBING I